Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
Travera Inc
Eastern Cooperative Oncology Group
Vanderbilt-Ingram Cancer Center
Eastern Cooperative Oncology Group
Mayo Clinic
Indiana University
M.D. Anderson Cancer Center
National Cancer Institute (NCI)